N
Novarex Co Ltd
KOSDAQ:194700
Novarex Co Ltd
KOSDAQ:194700
Price:
14 280
KRW
-1.45%
Market Closed
Market Cap:
267.8B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Novarex Co Ltd
14280
-210 (-1.45%)
| 52 Week Range |
6 680
22 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
Delete Alert
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Novarex Co Ltd
Novarex Co Ltd
|
Revenue
|
349.2B
KRW
|
|
Cost of Revenue
|
-295.4B
KRW
|
|
Gross Profit
|
53.8B
KRW
|
|
Operating Expenses
|
-22B
KRW
|
|
Operating Income
|
31.7B
KRW
|
|
Other Expenses
|
-4.6B
KRW
|
|
Net Income
|
27.1B
KRW
|
Income Statement
Novarex Co Ltd
Novarex Co Ltd
Currency: KRW
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
42
|
0
|
0
|
0
|
192
|
0
|
0
|
0
|
799
|
0
|
0
|
0
|
1 243
|
0
|
0
|
0
|
1 367
|
0
|
0
|
0
|
880
|
0
|
0
|
|
| Revenue |
51 633
N/A
|
81 679
+58%
|
107 311
+31%
|
115 108
+7%
|
126 944
+10%
|
139 892
+10%
|
159 101
+14%
|
178 452
+12%
|
198 365
+11%
|
212 541
+7%
|
222 832
+5%
|
235 083
+5%
|
243 612
+4%
|
254 281
+4%
|
278 790
+10%
|
294 840
+6%
|
303 910
+3%
|
294 213
-3%
|
281 675
-4%
|
272 600
-3%
|
270 545
-1%
|
292 877
+8%
|
302 167
+3%
|
289 459
-4%
|
295 175
+2%
|
291 969
-1%
|
297 725
+2%
|
331 881
+11%
|
349 186
+5%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||
| Cost of Revenue |
(40 964)
|
(65 272)
|
(86 646)
|
(94 041)
|
(104 023)
|
(115 000)
|
(130 486)
|
(146 724)
|
(164 691)
|
(176 085)
|
(183 629)
|
(193 072)
|
(201 888)
|
(213 908)
|
(237 346)
|
(252 807)
|
(259 103)
|
(250 188)
|
(241 258)
|
(234 861)
|
(233 051)
|
(251 510)
|
(258 235)
|
(246 589)
|
(251 344)
|
(249 597)
|
(254 492)
|
(282 508)
|
(295 418)
|
|
| Gross Profit |
10 668
N/A
|
16 406
+54%
|
20 665
+26%
|
21 068
+2%
|
22 922
+9%
|
24 892
+9%
|
28 615
+15%
|
31 727
+11%
|
33 673
+6%
|
36 456
+8%
|
39 203
+8%
|
42 011
+7%
|
41 724
-1%
|
40 373
-3%
|
41 443
+3%
|
42 034
+1%
|
44 807
+7%
|
44 025
-2%
|
40 417
-8%
|
37 739
-7%
|
37 494
-1%
|
41 367
+10%
|
43 932
+6%
|
42 870
-2%
|
43 832
+2%
|
42 371
-3%
|
43 233
+2%
|
49 373
+14%
|
53 768
+9%
|
|
| Operating Income | ||||||||||||||||||||||||||||||
| Operating Expenses |
(4 510)
|
(6 435)
|
(9 330)
|
(9 650)
|
(10 690)
|
(11 707)
|
(12 309)
|
(12 649)
|
(12 040)
|
(12 166)
|
(12 210)
|
(12 486)
|
(12 361)
|
(12 535)
|
(11 432)
|
(11 571)
|
(12 309)
|
(13 244)
|
(15 231)
|
(16 039)
|
(17 336)
|
(17 742)
|
(18 401)
|
(18 776)
|
(19 635)
|
(20 281)
|
(20 384)
|
(21 328)
|
(22 048)
|
|
| Selling, General & Administrative |
(4 510)
|
(6 157)
|
(8 253)
|
(8 850)
|
(9 890)
|
(10 815)
|
(10 887)
|
(11 446)
|
(10 458)
|
(10 325)
|
(10 005)
|
(10 455)
|
(10 388)
|
(10 813)
|
(10 980)
|
(11 080)
|
(11 754)
|
(12 050)
|
(12 500)
|
(12 573)
|
(13 227)
|
(13 776)
|
(14 369)
|
(14 793)
|
(15 438)
|
(15 797)
|
(15 708)
|
(16 591)
|
(17 432)
|
|
| Research & Development |
0
|
(235)
|
(898)
|
0
|
0
|
(636)
|
(1 008)
|
(781)
|
(1 021)
|
(1 347)
|
(1 649)
|
(1 487)
|
(1 443)
|
(1 191)
|
0
|
(616)
|
(659)
|
(1 287)
|
(2 141)
|
(2 849)
|
(3 478)
|
(3 318)
|
(3 370)
|
(3 319)
|
(3 506)
|
(3 724)
|
(3 851)
|
(3 847)
|
(3 675)
|
|
| Depreciation & Amortization |
0
|
(44)
|
(179)
|
0
|
0
|
(256)
|
(414)
|
(422)
|
(561)
|
(494)
|
(556)
|
(545)
|
(531)
|
(531)
|
(536)
|
(544)
|
(564)
|
(575)
|
(590)
|
(616)
|
(631)
|
(647)
|
(661)
|
(665)
|
(691)
|
(760)
|
(824)
|
(890)
|
(941)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
(800)
|
(800)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
84
|
668
|
668
|
668
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
6 159
N/A
|
9 972
+62%
|
11 335
+14%
|
11 417
+1%
|
12 231
+7%
|
13 185
+8%
|
16 306
+24%
|
19 078
+17%
|
21 633
+13%
|
24 289
+12%
|
26 993
+11%
|
29 524
+9%
|
29 362
-1%
|
27 837
-5%
|
30 012
+8%
|
30 462
+2%
|
32 497
+7%
|
30 781
-5%
|
25 186
-18%
|
21 700
-14%
|
20 158
-7%
|
23 625
+17%
|
25 531
+8%
|
24 094
-6%
|
24 197
+0%
|
22 090
-9%
|
22 849
+3%
|
28 045
+23%
|
31 720
+13%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||
| Interest Income Expense |
357
|
284
|
384
|
1 081
|
518
|
536
|
631
|
(42)
|
162
|
472
|
(438)
|
140
|
(290)
|
(169)
|
281
|
(281)
|
163
|
212
|
(585)
|
(667)
|
(777)
|
(828)
|
690
|
1 601
|
2 469
|
652
|
5 686
|
4 497
|
1 666
|
|
| Non-Reccuring Items |
0
|
0
|
(260)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(158)
|
0
|
0
|
0
|
(61)
|
0
|
0
|
0
|
263
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
39
|
0
|
0
|
0
|
(149)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(102)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
21
|
0
|
0
|
|
| Total Other Income |
(30)
|
(7)
|
(11)
|
(337)
|
(276)
|
(200)
|
226
|
160
|
336
|
219
|
261
|
336
|
281
|
370
|
458
|
141
|
88
|
29
|
(169)
|
(126)
|
(67)
|
62
|
13
|
(110)
|
(191)
|
(395)
|
(147)
|
(13)
|
182
|
|
| Pre-Tax Income |
6 486
N/A
|
10 249
+58%
|
11 487
+12%
|
12 162
+6%
|
12 474
+3%
|
13 522
+8%
|
17 015
+26%
|
19 197
+13%
|
22 131
+15%
|
24 981
+13%
|
26 801
+7%
|
30 001
+12%
|
29 354
-2%
|
28 039
-4%
|
30 648
+9%
|
30 322
-1%
|
32 749
+8%
|
31 022
-5%
|
24 245
-22%
|
20 907
-14%
|
19 314
-8%
|
22 859
+18%
|
26 142
+14%
|
25 585
-2%
|
26 476
+3%
|
22 347
-16%
|
28 673
+28%
|
32 529
+13%
|
33 568
+3%
|
|
| Net Income | ||||||||||||||||||||||||||||||
| Tax Provision |
(1 083)
|
(1 723)
|
(2 335)
|
(2 515)
|
(2 599)
|
(2 810)
|
(2 508)
|
(1 327)
|
(1 825)
|
(2 230)
|
(1 802)
|
(3 387)
|
(3 376)
|
(3 066)
|
(4 336)
|
(4 318)
|
(5 927)
|
(5 838)
|
(4 303)
|
(4 083)
|
(2 300)
|
(2 922)
|
(4 168)
|
(3 988)
|
(3 995)
|
(3 084)
|
(4 834)
|
(5 337)
|
(5 668)
|
|
| Income from Continuing Operations |
5 403
|
8 526
|
9 152
|
9 647
|
9 876
|
10 713
|
14 506
|
17 871
|
20 306
|
22 750
|
25 000
|
26 613
|
25 977
|
24 973
|
26 313
|
26 004
|
26 822
|
25 184
|
19 942
|
16 824
|
17 014
|
19 937
|
21 974
|
21 597
|
22 480
|
19 263
|
23 838
|
27 192
|
27 900
|
|
| Income to Minority Interest |
104
|
187
|
338
|
328
|
338
|
316
|
203
|
192
|
167
|
149
|
145
|
159
|
166
|
162
|
89
|
60
|
38
|
(6)
|
44
|
74
|
26
|
5
|
62
|
(118)
|
(292)
|
(499)
|
(822)
|
(793)
|
(778)
|
|
| Net Income (Common) |
5 506
N/A
|
8 712
+58%
|
9 490
+9%
|
9 974
+5%
|
10 213
+2%
|
11 028
+8%
|
14 709
+33%
|
18 062
+23%
|
20 473
+13%
|
22 900
+12%
|
25 145
+10%
|
26 773
+6%
|
26 144
-2%
|
25 135
-4%
|
26 401
+5%
|
26 064
-1%
|
26 860
+3%
|
25 178
-6%
|
19 986
-21%
|
16 897
-15%
|
17 040
+1%
|
19 942
+17%
|
22 036
+11%
|
21 479
-3%
|
22 188
+3%
|
18 763
-15%
|
23 017
+23%
|
26 399
+15%
|
27 122
+3%
|
|
| EPS (Diluted) |
688.25
N/A
|
1 089
+58%
|
1 186.25
+9%
|
1 246.75
+5%
|
1 276.62
+2%
|
1 378.5
+8%
|
1 838.62
+33%
|
2 257.75
+23%
|
2 559.12
+13%
|
2 862.5
+12%
|
3 143.12
+10%
|
3 346.62
+6%
|
1 615.11
-52%
|
1 552.77
-4%
|
1 631.01
+5%
|
1 610.16
-1%
|
1 659.36
+3%
|
2 355.15
+42%
|
1 206.27
-49%
|
954.52
-21%
|
962.6
+1%
|
1 126.52
+17%
|
1 244.81
+11%
|
1 213.34
-3%
|
1 253.42
+3%
|
1 059.94
-15%
|
1 300.22
+23%
|
1 491.3
+15%
|
1 532.11
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
